- Home
- HCKT vs HQL Comparison
HCKT vs HQL Comparison
Compare HCKT & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCKT
- HQL
- Stock Information
- Founded
- HCKT 1991
- HQL 1992
- Country
- HCKT United States
- HQL United States
- Employees
- HCKT N/A
- HQL N/A
- Industry
- HCKT Professional Services
- HQL Investment Managers
- Sector
- HCKT Consumer Discretionary
- HQL Finance
- Exchange
- HCKT Nasdaq
- HQL Nasdaq
- Market Cap
- HCKT 545.3M
- HQL 440.3M
- IPO Year
- HCKT 1998
- HQL N/A
- Fundamental
- Price
- HCKT $19.10
- HQL $15.94
- Analyst Decision
- HCKT Strong Buy
- HQL
- Analyst Count
- HCKT 3
- HQL 0
- Target Price
- HCKT $29.67
- HQL N/A
- AVG Volume (30 Days)
- HCKT 228.9K
- HQL 120.9K
- Earning Date
- HCKT 11-03-2025
- HQL 01-01-0001
- Dividend Yield
- HCKT 2.51%
- HQL 11.56%
- EPS Growth
- HCKT N/A
- HQL N/A
- EPS
- HCKT 0.59
- HQL 0.79
- Revenue
- HCKT $309,265,000.00
- HQL N/A
- Revenue This Year
- HCKT $2.33
- HQL N/A
- Revenue Next Year
- HCKT $4.84
- HQL N/A
- P/E Ratio
- HCKT $32.28
- HQL $17.08
- Revenue Growth
- HCKT 3.98
- HQL N/A
- 52 Week Low
- HCKT $18.74
- HQL $11.34
- 52 Week High
- HCKT $34.02
- HQL $14.37
- Technical
- Relative Strength Index (RSI)
- HCKT 37.23
- HQL 77.68
- Support Level
- HCKT $18.74
- HQL $15.60
- Resistance Level
- HCKT $19.30
- HQL $15.95
- Average True Range (ATR)
- HCKT 0.35
- HQL 0.26
- MACD
- HCKT 0.02
- HQL 0.10
- Stochastic Oscillator
- HCKT 26.15
- HQL 94.45
About HCKT Hackett Group Inc (The).
The Hackett Group Inc is an IP platform-based Generative Artificial Intelligence (Gen AI) strategic consulting and executive advisory digital transformation firm. The Hackett Group provides dedicated expertise in Gen AI-enabled enterprise transformation services across the front, mid and back office areas, including its highly recognized Oracle, SAP, OneStream and Coupa implementation offerings. It operates in three segments Oracle Solutions, SAP Solutions, and Global S&BT. It generates the majority of its revenue from the Global S&BT segment in the United States.
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mostly in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have potential for above-average growth.